Article citationsMore>>

Missiaglia, E., Williamson, D., Chisholm, J., et al. (2012) PAX3/FOXO1 Fusion Gene Status Is the Key Prognostic Molecular Marker in Rhabdomyosarcoma and Significantly Improves Current Risk Stratification. Journal of Clinical Oncology, 30, 1670-1677.
http://dx.doi.org/10.1200/JCO.2011.38.5591

has been cited by the following article:

• TITLE: Description of a Triad of Rare Malignancies in a Single Patient

  AUTHORS: David Fackrell, Yen Yeo, Nawaz Walji

  KEYWORDS: Granulosa Cell Tumour, Sertoli-Leydig Tumour, Rhabdomyosarcoma, Forkhead Transcription Factor Proteins

  JOURNAL NAME: Case Reports in Clinical Medicine, Vol.4 No.3, March 20, 2015

  ABSTRACT: We describe the case of a patient diagnosed with a rhabdomyosarcoma and two distinctly separate non-epithelial ovarian cancers. Granulosa cell tumour and Sertoli-Leydig tumour are rare tumours accounting for less than 10% of all ovarian malignancies. Rhabdomyosarcoma is also rare and more commonly seen in childhood. We link these tumours to a mutation in the forkhead transcription factor proteins.